Comment on CMS-2026-1255-0001

Summary: The National Alliance on Mental Illness (NAMI) supports the proposed rule to expand electronic prior authorization standards to prescription drugs and improve interoperability. They argue that these measures are essential for reducing administrative burdens and ensuring timely access to mental health treatments, while also recommending specific protections for patient privacy and continuity of care.